Relation between irinotecan-induced cholinergic syndrome and prognosis of colorectal cancer patients.

被引:3
|
作者
Fujii, Hiroyuki
Hirata, Taizo
Mura, Takuya
Okada, Yuko
Tashiro, Hirotaka
机构
[1] NHO Kure Med Ctr, Kure, Japan
[2] Chugoku Canc Ctr, Kure, Japan
关键词
D O I
10.1200/JCO.2018.36.4_suppl.859
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
859
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer
    Ayako Tsuboya
    Ken-ichi Fujita
    Yutaro Kubota
    Hiroo Ishida
    Iori Taki-Takemoto
    Daisuke Kamei
    Shinichi Iwai
    Yasutsuna Sasaki
    International Journal of Clinical Oncology, 2019, 24 : 222 - 230
  • [2] Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer
    Tsuboya, Ayako
    Fujita, Ken-ichi
    Kubota, Yutaro
    Ishida, Hiroo
    Taki-Takemoto, Iori
    Kamei, Daisuke
    Iwai, Shinichi
    Sasaki, Yasutsuna
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (02) : 222 - 230
  • [3] Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer
    Okunaka, Mashiro
    Kano, Daisuke
    Matsui, Reiko
    Kawasaki, Toshikatsu
    Uesawa, Yoshihiro
    PHARMACEUTICALS, 2021, 14 (04)
  • [4] Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients
    Kehrer, DFS
    Sparreboom, A
    Verweij, J
    de Bruijn, P
    Nierop, CA
    van de Schraaf, J
    Ruijgrok, EJ
    de Jonge, MJA
    CLINICAL CANCER RESEARCH, 2001, 7 (05) : 1136 - 1141
  • [5] Oxyresveratrol Alleviates Irinotecan-Induced Diarrhea and Enhances Antitumor Effects in Colorectal Cancer
    Yang, Xing
    Yu, Hengxiang
    Zhou, Liming
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 6283 - 6295
  • [6] Irinotecan-Induced Transient Dysarthria in a Patient With Metastatic Colorectal Cancer: A Case Report
    Inting, Kim Alfred E.
    Piano, Anthony N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [7] Alleviation of Abdominal Pain due to Irinotecan-Induced Cholinergic Syndrome Using Loperamide: A Case Report
    Uchiyama, Kazuki
    Saito, Yoshitaka
    Takekuma, Yoh
    Yuki, Satoshi
    Sugawara, Mitsuru
    CASE REPORTS IN ONCOLOGY, 2021, 14 (02): : 806 - 811
  • [8] Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: A prospective assessment
    Saliba, F
    Hagipantelli, R
    Misset, JL
    Bastian, G
    Vassal, G
    Bonnay, M
    Herait, P
    Cote, C
    Mahjoubi, M
    Mignard, D
    Cvitkovic, E
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2745 - 2751
  • [9] An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
    W Ichikawa
    K Uehara
    K Minamimura
    C Tanaka
    Y Takii
    H Miyauchi
    S Sadahiro
    K Fujita
    T Moriwaki
    M Nakamura
    T Takahashi
    A Tsuji
    K Shinozaki
    S Morita
    Y Ando
    Y Okutani
    M Sugihara
    T Sugiyama
    Y Ohashi
    Y Sakata
    British Journal of Cancer, 2015, 112 : 1709 - 1716
  • [10] An internally and externally validated nomogram for predicting the risk of irinotecan-induced severe neutropenia in advanced colorectal cancer patients
    Ichikawa, W.
    Uehara, K.
    Minamimura, K.
    Tanaka, C.
    Takii, Y.
    Miyauchi, H.
    Sadahiro, S.
    Fujita, K.
    Moriwaki, T.
    Nakamura, M.
    Takahashi, T.
    Tsuji, A.
    Shinozaki, K.
    Morita, S.
    Ando, Y.
    Okutani, Y.
    Sugihara, M.
    Sugiyama, T.
    Ohashi, Y.
    Sakata, Y.
    BRITISH JOURNAL OF CANCER, 2015, 112 (10) : 1709 - 1716